PROLASTIN® celebrates 25 years as leading augmentation therapy for treatment of alpha(1)-antitrypsin deficiency

[PR Newswire] – RESEARCH TRIANGLE PARK, N.C., Feb. 5, 2013 /PRNewswire/ — Grifols, a global healthcare company based in Barcelona, Spain, is commemorating the 25 th anniversary year of PROLASTIN ® (alpha 1 -proteinase … more

View todays social media effects on GRF

View the latest stocks trending across Twitter. Click to view dashboard

See who Eagle is hiring next, click here to view